Journal
NATURE BIOTECHNOLOGY
Volume 35, Issue 1, Pages 56-68Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nbt.3745
Keywords
-
Categories
Funding
- Canadian Institute of Health Research (CIHR) [MOP-84524, MOP-83453]
- European Research Council Ideas-Program (ERC) [ERC-2010-StG-260830-Cardio-iPS]
- Technion-UHN International Centre for Cardiovascular Innovation collaboration
- Banting postdoctoral fellowship
Ask authors/readers for more resources
The sinoatrial node (SAN) is the primary pacemaker of the heart and controls heart rate throughout life. Failure of SAN function due to congenital disease or aging results in slowing of the heart rate and inefficient blood circulation, a condition treated by implantation of an electronic pacemaker. The ability to produce pacemaker cells in vitro could lead to an alternative, biological pacemaker therapy in which the failing SAN is replaced through cell transplantation. Here we describe a transgene-independent method for the generation of SAN-like pacemaker cells (SANLPCs) from human pluripotent stem cells by stage-specific manipulation of developmental signaling pathways. SANLPCs are identified as NKX2-5(-) cardiomyocytes that express markers of the SAN lineage and display typical pacemaker action potentials, ion current profiles and chronotropic responses. When transplanted into the apex of rat hearts, SANLPCs are able to pace the host tissue, demonstrating their capacity to function as a biological pacemaker.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available